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Available online 12 December 2015Neural precursor cells (NPCs) in the adult mammalian brain demonstrate potential in applications of neural re-
pair in the CNS. Recent work has shown that cyclosporin A (CsA), a commonly used immunosuppressive drug,
expands the size of theNPC pool in the subventricular region by promoting cell survival.Weasked if CsAhad sim-
ilar effects on NPCs in the dentate gyrus (DG) of the hippocampus, leading to increased neurogenesis. We used
the in vitro and in vivo assays to examine CsA's effect on the size of the NPC pool and the proliferation and differ-
entiation proﬁle of cells within the DG. We found that CsA increases the numbers of NPCs and enriches for neu-
rogenic NPCs in vitro. Similarly, in vivo systemic administration of CsA for 7 days increases the size of the NPC
pool in the DG observed through increases in numbers of proliferating cells and newborn neurons. Consistent
with CsA's pro-survival effects,we have shown that CsA enhances the survival of newborn cells that normally un-
dergo cell death over the time of infusion. Together theseﬁndings support thehypothesis that CsA administration
promotes neurogenesis and may have implications for neural repair.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Survival1. Introduction
Neurogenesis, the production of new neurons, has been shown to
occur in two areas in the adult brain: the subventricular zone (SVZ)
that lines the lateral ventricles (LV) (Reynolds and Weiss, 1992;
Luskin, 1993) and the dentate gyrus (DG) of the hippocampus
(Alvarez-Buylla et al., 2002). The SVZ and DG have both been shown
to contain multipotent self-renewing neural stem cells and their proge-
ny, which are collectively termed neural precursor cells (NPCs)
(Morshead et al., 1994; Roy et al., 2000). In the SVZ, NPCs proliferate
and migrate along the rostral migratory stream to the olfactory bulb
where they differentiate and mature into interneurons (Doetsch et al.,
1999). In the DG, as demonstrated through the use of proliferation
markers, such as 5-bromo-2-deoxyuridine (BrdU), and various neuro-
nal markers, new neurons arise from NPCs in the subgranular zone
(SGZ) where they proliferate and generate neuroblasts that migrate
into the overlying granule cell layer where they mature into excitatory
neurons (Kuhn et al., 1996; Seri et al., 2001; van Praag et al., 2002). Inoxyuridine; DCX, doublecortin;
basic ﬁbroblast growth factor;
NPC, neural precursor cell; SVZ,
nular zone.
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. This is an open access article underboth neurogenic regions of the brain, many of the newborn cells under-
go cell death within their respective lineages. In the SVZ, 60% of the
newborn cells undergo cell death over a 6-day period (Morshead
et al., 1994) and in the DG, 50% of the newborn neurons die under base-
line conditions (McDonald and Wojtowicz, 2005). Accordingly, it is in-
teresting to consider cell survival strategies as a means to enhance
neurogenesis in vivo.
A drug that has been shown to have a direct, pro-survival effect on
SVZ-derived NPCs is cyclosporin A (CsA) (Hunt et al., 2010). CsA is an
immunosuppressive drug used commonly in clinical settings to prevent
graft rejection in organ transplantation (Dreyfuss et al., 1976; Borel
et al., 1977). Hunt et al. (2010) used in vitro and in vivo analyses to
show that CsA had direct, pro-survival effects on SVZ-derived NPCs.
The pro-survival effects were shown to be mediated by a calcineurin-
independent pathwaywhich promotes survival by inhibitingmitochon-
drial permeability transition (MPT) pore formation (Sachewsky et al.,
2014). Most interesting, administration of CsA was shown to promote
tissue repair in a mouse model of stroke (Erlandsson et al., 2011;
Sachewsky et al., 2014). Based on these ﬁndings, we asked whether
CsA had similar effects on the NPC population within the neurogenic
DG of the hippocampus.
Herewe show that CsA administration results in an expansion of the
size of the NPC pool in the DG using both in vitro and in vivo assays. CsA
administration in vivo promotes neurogenesis, consistent with its role
in enhancing cell survival. Given the role of the hippocampus in learning
and memory, promoting cell survival and neurogenesis within thisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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brain and enhance neural repair.
2. Materials and methods
2.1. Animals
All experiments were performed on 2 to 4month oldmale CD1mice
(Charles River, Wilmington, MA, www.criver.com). All animals were
housed in the University of Toronto animal facilities and maintained
in accordance with institutional guidelines. Experimental procedures
were performed in accordancewith the Guide to Care and Use of Exper-
imental Animals and approved by the Animal Care Committee at the
University of Toronto.
2.2. Neurosphere assay
Mice were sacriﬁced by cervical dislocation. Mouse brains were em-
bedded in 2% low-gelling temperature agarose (Sigma-Aldrich, St. Louis,
MO, www.sigmaaldrich.com) for 20 min at 4 °C. The embedded brain
was then sectioned on a vibratome into 300–500 μm thick slices. The
DG was removed under a dissecting microscope (Zeiss, Jana, Germany,
www.zeiss.com). Both the brain slices and the DG tissue were kept in
artiﬁcial cerebrospinal ﬂuid (aCSF) containing 124 mM NaCl, 5 mM
KCl, 1.3 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM D-
glucose. DG tissue was then dissociated using trypsin 13,000 U/10 mL,
hyaluronidase 1300 U/10 mL, and kynurenic acid 1.33 mg/10 mL in
aCSF consisting of a higher concentration of Mg2+ (3.2 mM MgCl2)
and lower Ca2+ (0.1 mM CaCl2) (hi–lo aCSF) for 25 min at 37 °C in Fal-
con tubes thatwere gently rocked during this time. After incubation and
rocking, the tissue was spun down in a centrifuge and the trypsin en-
zyme solution was removed. The tissue was then resuspended in SFM
with 0.67 mg/mL trypsin inhibitor (Roche Diagnostics) and triturated
using a small bore glass pipette. Cells were washed and resuspended
in serum-free media (SFM) supplemented with epidermal growth
factor (EGF) (20 ng/mL; Sigma-Aldrich), basic ﬁbroblast growth factor
(bFGF) (10 ng/mL; Sigma-Aldrich), heparin (7.35 ng/mL; Sigma-
Aldrich), B27 (1X; Invitrogen), and 1% penicillin/streptomycin
(Invitrogen). Cell viability was assayed using Trypan blue exclusion be-
fore live cells were plated at clonal density of 10 cells per μL in uncoated
24-well plates (Nunclon, Rochester, NY, www.nuncbrand.com). A stock
solution of CsA (0.2 mg/mL; Bioshop Canada) consisted of dissolving
solid CsA in anhydrous ethyl alcohol:growth factor-supplemented
SFM solution in a 1:1 ratio and subsequently added to the cultures at
concentrations ranging from0 to 1000 ng/mL. A separate 1:1 anhydrous
ethyl alcohol:growth factor-supplemented SFM solution was made
without CsA for control conditions. Neurospheres N50 μm in diameter
were quantiﬁed after 7 days of undisturbed culture (Clarke and van
der Kooy 2011). Neurosphere size was measured using an ocular
micrometer.
For bulk passaging, cultures were grown in the continued presence
or continued absence of 100 ng/mL CsA for 7 days before collecting
the neurospheres, dissociating and replating in the same conditions.
For differentiation assays, single neurospheres were picked from each
condition and plated onto laminin-coated wells in the presence of 10%
FBS for 7 days, with or without 100 ng/mL CsA such that neurospheres
grown in the presence of CsA were also differentiated in the presence
of CsA and spheres grownwithout CsAwere differentiatedwithout CsA.
2.3. Live/dead cell viability assay
Brieﬂy, neurospheres were collected into 1.5 mL tubes (Eppendorf)
and centrifuged for 3 min at 2000 rpm. The supernatant was removed
and 200 μL of TrypLE (Gibco) was added. The neurospheres were gently
triturated and left to incubate at room temperature for 5min. Live/dead
(Invitrogen) assay mixture was prepared in SFM at ratios of 1:2000 forthe 2 mM calcein-AM stock component and 1:500 for the 4 mM EthD-
1 stock component. Neurospheres were centrifuged again after incuba-
tionwith TrypLE for 3min at 2000 rpm and the TrypLE supernatant was
removed. The live/dead assay mixture was then added to the
neurospheres followed with gentle trituration. The dissociated cells
were then transferred to a 24-well plate and allowed to incubate for
25 min at 37 °C before imaging under a ﬂuorescent microscope
(Axiovert 200, Carl Zeiss) at 100× magniﬁcation. Four ﬁelds of view
were sampled per well.
2.4. In vivo studies
Adult male CD1 mice (2 to 4 months, 25–30 g; Charles River) re-
ceived CsA (15 mg/kg/day) or vehicle delivered subcutaneously via an
osmotic minipump (Alzet Osmotic Pumps, Model 1007D) at a rate of
0.1 μL per hour for 7 days. Pumpswere inserted subcutaneously through
a 5–10mm incision located on the back of themouse, and placed poste-
rior to the scapulae, under anesthesia and sterile conditions. To examine
proliferation in vivo, mice received three BrdU injections (60 mg/kg;
one every 2 h) andwere killed 2 h after the last injection.Micewere per-
fused transcardially with 4 °C sterile 1× PBS followed by 4% (in sterile
1× PBS) paraformaldehyde (PFA) (4 °C). Brains were post-ﬁxed
overnight in 4% PFA and cryoprotected in 20% sucrose (Sigma-Aldrich)
at 4 °C. Brains were coronally cryosectioned into 18 μm thin sections
at −20 °C and mounted on Superfrost slides (Fisher Scientiﬁc) for
immunohistochemistry. Tissue sections were taken from −1.45 mm
to −3.4 mm from bregma, establishing series of every 5th section
through the DG. A separate group of animals received daily BrdU
injections (60 mg/kg) for 7 days prior to having CsA or vehicle pumps
implanted as described for 7 days. These animals were perfused and
cryosectioned as described above.
2.5. Immunohistochemistry
Neurospheres were ﬁxed in 4% paraformaldehyde for 20 min at
room temperature and washed (all washes are performed three times,
ﬁveminutes per rinse using 1× Stockholm's PBS). Frozen tissue sections
were thawed to room temperature and re-hydrated with 1× PBS.
Neurosphere cells and brain sectionswere permeabilizedusing 0.3% Tri-
ton X-100 (Sigma-Aldrich) for 20min, washed, and blocked with either
10% normal goat serum (NGS; Jackson Laboratories) or 10% normal
donkey serum for 1 h at room temperature. Antibodies were diluted
1× Stockholm's PBS plus 10% serum. Cells or tissue was incubated
with primary antibodies overnight at 4 °C, washed, and incubated
with an appropriate secondary antibody for 1 h at 37 °C, washed, and
ﬂuorescently imaged at 200× magniﬁcation using an Axiovert 200
(Carl Zeiss). Differentiated neurosphere cells were stained for O4
(mouse monoclonal IgM, 1:1000, R&D Systems), βIII-tubulin (rabbit
polyclonal IgG, 1:1000, Covance), and GFAP (mouse, 1:500, Sigma). Tis-
sue sections were labeled for Ki67 (rabbit polyclonal IgG, 1:200;
Abcam), DCX (goat polyclonal IgG, 1:200; Santa Cruz Biotechnology).
The secondary antibodies used were: Alexa Fluor 647 goat anti-mouse
IgG; Alexa Fluor 568 goat anti-mouse IgM; Alexa Fluor 488 goat anti-
rabbit IgG; Alexa Fluor donkey anti-goat IgG (all 1:400; Invitrogen).
Cell nuclei were counterstained with Hoechst 33342 nuclear stain
(0.725 μg/mL; Invitrogen) for 10 min at 37 °C and washed. For BrdU
labeling, brain sections mounted on slides were treated with 1 N
hydrochloric acid (Sigma-Aldrich) for 20 min at 65 °C, washed, and
incubated with BrdU antibody (rat monoclonal IgG, 1:100; Abcam) over-
night at 4 °C. Slideswerewashed and incubatedwithAlexa Fluor 488 goat
anti-rat IgG for 2 h at 37 °C, washed, and then ﬂuorescently imaged.
2.6. Statistical analysis
Statistical analysis was performed using the Student's t test for two-
group comparisons and ANOVA for multiple group comparisons
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less otherwise stated. *p b 0.05, **p b 0.01, ***p b 0.001.
3. Results
3.1. Cyclosporin A increases the numbers but not the size of clonally derived
neurospheres
Neural precursor cells can be isolated in vitro from the DGwhen cul-
tured in the presence of growth factors where they form free-ﬂoating,
clonally derived colonies called “neurospheres” (Reynolds and Weiss,
1992; Seaberg and van der Kooy, 2002; Clarke and van der Kooy, 2011).
In previous studies by Hunt et al. (2010), CsAwas shown to increase
both the number of neurospheres derived from the SVZ. We asked
whether CsA would have similar effects on the number of NPCs derived
from the DG. Adult primary hippocampal tissue was carefully dissected
to ensure that SVZ NPCs found in the walls of the lateral ventricles were
not included in the dissection (Fig. 1A). Cells were triturated and plated
at clonal density (10 cells/uL) in the neurosphere assay in a range of CsA
concentrations (range 0 to 1000 ng/ml). The numbers of neurospheres
was counted after 7 days in vitro. At a concentration of 100 ng/mL of
CsA, we observed a signiﬁcant 1.9-fold increase in the number of
neurospheres (1.01 ± 0.14 neurospheres vs. 0.54 ± 0.08 per 5000
cells; in 100 ng/mL CsA vs. control respectively; F4,93 = 2.56, p =
0.04 b 0.05, in 1-way ANOVA) (Fig. 1B). The average size of the
neurosphere was unchanged in the presence or absence of CsA (F4,93 =
0.88, p=0.48, in 1-wayANOVA) suggesting that the proliferation kinetics
of the NPCs forming the neurospheres was not altered (Fig. 1C).
We hypothesized that since neural stem cells (the founder cell for an
individual neurospheres) comprise a small subset of the cells within a
growing neurosphere (Morshead et al., 2002), an expansion in theirFig. 1.Cyclosporin A increased neurosphere numbers but not size. (A) Representative images of
(B) CsAwas added at doses ranging from 0 to 1000 ng/mL, resulting in a 1.9 fold increase in neu
way ANOVA, n=22mice over 10 independent trials). (C) CsA had no signiﬁcant effect on the n
in (+) CsA or (−) CsA conditions continuously for 3 passages. Continual passage in 100 ng/mL o
P1. There was no signiﬁcant increase between P3 and P1 in−CsA conditions.numbers would be difﬁcult to detect when looking at the size of a
neurosphere. We predicted that if CsA was enhancing neural stem
cell survival, then we should observe an expansion in the number
of neurospheres with passaging. Neurospheres from 0 ng/ml and
100 ng/ml conditions were collected and bulk passaged in the ab-
sence or presence of CsA (100 ng/ml) at clonal densities for 3 consec-
utive passages. We found the number of neurospheres in CsA
conditions expanded signiﬁcantly over control resulting in a 3.46-fold
increase in the number of neurospheres at passage 3 (P3) compared
to P1 (99.5 ± 42.1 vs. 28.7 ± 5.6; P3 vs. P1 respectively, p =
0.04 b 0.05) (Fig. 1D). Without CsA, the expansion between P1 to P3
was not signiﬁcant (18.6 ± 4.5 in P1 vs. 40.4 ± 22.8 in P3, p = 0.31).
We observed no change in the size of the neurospheres at each consec-
utive passage in the continued presence of CsA (+CsA) (data not
shown), supporting the hypothesis that CsA is promoting symmetric di-
vision and survival of neural stem cells and not the downstream
progeny.
3.2. Cyclosporin A reduces cell death in neurospheres in vitro
As a further test to examine cell survivalwithin the neurosphere cul-
tures, we performed the live/dead cell viability assay on neurospheres
grown in the presence or absence of 100 ng/mL of CsA. If CsA enhances
cell survival, we predict a lower percentage of dead cells in
neurospheres grown in the presence of CsA as was observed with line-
age tracking using SVZ neurospheres (Hunt et al., 2010). We observed a
signiﬁcant 1.79-fold decrease in the percentage of dead cells in CsA ver-
sus untreated cultures (19.3% ± 1.5% in CsA vs. 34.6% ± 2.8% control,
**p= 0.003 b 0.05, n= 4) (Fig. 2). Hence, similar to what was observed
with SVZ-derived neurosphere cultures (Hunt et al., 2010), CsA pro-
motes cell survival of neural precursor cells.the dissection of the dentate gyrus from adultmouse brain tissue slice 500 μm in thickness.
rosphere number in 100 ng/mL CsA relative to vehicle controls (F4,93= 2.56, p b 0.05, in 1-
eurosphere size at any dose (n=8 independent trials). (D) Passaging neurospheres grown
f CsA led to signiﬁcant increase in the average number of neurospheres at P3 compared to
Fig. 2. Cyclosporin A reduces cell death in neurospheres in vitro. (A) We observed a signiﬁcant 1.79-fold decrease in the percentage of dead cells in CsA versus untreated cultures
(19.3%± 1.5 in CsA vs. 34.6%± 2.8% control, **p= 0.003 b 0.05, n= 4 animals per condition). (B) Representative images of live/dead assay. Live cells are indicated by green and dead
cells are indicated by red. Scale bars represent 100 μm.
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Wenext sought to determinewhether CsA affects the differentiation
proﬁle of hippocampal neurospheres. Single neurospheres were plated
in differentiation conditions containing 10% FBS and SFM in the pres-
ence or absence of 100 ng/mL of CsA. Neurospheres that had not yet
been passaged but were grown and differentiated in the presence of
CsA (+CsA) displayed a signiﬁcant increase in the frequency of
neuron-containing neurospheres, as determined by the expression of
the neuronal marker β-III-tubulin, compared to control neurospheres
(grown and differentiated in the absence of CsA) (−CsA) (81 ± 8.7%
vs. 19 ± 8.7% in 100 ng/mL CsA vs. control respectively; F3,16 = 5.52,**p = 0.009 b 0.05, in 1-way ANOVA) (Fig. 3A). Neurospheres from P3
cultures in +CsA revealed a 7-fold increase in the relative frequency
of neuron-containing neurospheres relative to glia only containing
clones (87± 11% vs. 13± 6.4% in 100 ng/mL CsA vs. control respective-
ly; F3,8 = 25.7, ***p = 0.0002 b 0.05, in 1-way ANOVA) (Fig. 3B). Fur-
ther, the frequency of glial-only spheres signiﬁcantly decreased at P3
in +CsA conditions relative to−CsA condition (Fig. 3B) whereas pas-
saging the spheres in the absence of CsA revealed no change in the fre-
quencies of glial only and neurogenic spheres (P1 versus P3) (Fig. 2A
and 2B),−CsA condition, p N 0.05). Taken together, these ﬁndings re-
veal that the continued presence of CsA enhances survival of NPCs
that have the capacity to form neurons.
Fig. 3. Cyclosporin A increases the frequency of neurogenic neurospheres. (A) At P0, +CsA conditions signiﬁcantly increases the frequency of neurogenic spheres over control−CsA con-
ditions. (81± 8.7% vs. 19± 8.7% in 100 ng/mL CsA vs. control respectively; F3,16= 5.52, **p= 0.009 b 0.05, in 1-way ANOVA). (B) At P3, the frequency of neurogenic spheres signiﬁcantly
increases in (+)CsA conditions relative to P3 (−)CsA conditions (87 ± 11% vs. 13 ± 6.4% in 100 ng/mL CsA vs. control respectively; F3,8 = 25.7, ***p= 0.0002 b 0.05, in 1-way ANOVA).
(C) Representative images of O4 (red), β-III-tubulin (green), and GFAP (white) cells all stained with Hoechst to label nuclei (blue). *p b 0.05 **p b 0.01 ***p b 0.001. For P0 experiments,
n = 6 animals per group and for P3, n = 4 animals per group. Scale bars represent 50 μm.
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To examine the effects of in vivo administration of CsA on hippocam-
pal NPCs mice received systemic administration of CsA or vehicle for
7 days with subcutaneous pumps. We predicted that CsA infused mice
would give rise to increased numbers of neurospheres (Hunt et al.,
2010). Mice were sacriﬁced and hippocampal cells were plated in the
neurosphere assay in the absence of CsA. We observed a signiﬁcant
1.8-fold increase in the number of neurospheres from mice that re-
ceived CsA compared to vehicle infused mice (2.0 ± 0.18 vs. 1.1 ±
0.14 neurospheres; CsA versus vehicle treated mice respectively)
(**p = 0.001 b 0.01). This 1.8-fold increase is similar to the 2.6-fold in-
crease seen in SVZ-derived neurospheres following CsA administration
in vivo (Hunt et al., 2010). Thus, CsA can effectively increase the size
of the NPC pool in the adult brain in vivo.
3.5. Cyclosporin A infusion increases the population of NPCs and
neurogenesis in the DG
Next we examined the size of the NPC population and survival of
NPCs in the DG in the presence of CsA in vivo. First, we examined the
number of proliferating cells after 7 days of CsA infusion because this
is a time when we see the increased numbers of neurospheres
in vitro. Mice received 3 BrdU injections (once every two hours) tolabel actively dividing cells and were sacriﬁced 2 h after the last injec-
tion (Fig. 4A) and the numbers of BrdU labeled cells in the DG was
assessed. We observed signiﬁcant 1.7-fold increase in the numbers of
BrdU positive cells in CsA treated mice (9.8 ± 1.1 vs. 5.9 ± 0.9 cells
per section; CsA vs. vehicle infusedmice, p=0.02 b 0.05) (Fig. 4B). Con-
sistent with this ﬁnding, we observed a signiﬁcant 2.3-fold increase in
the numbers of Ki67 positive cells in the DG of CsA treated mice
(9.6 ± 2.9 vs. 5.8 ± 2.5 cells per section; CsA vs. vehicle infused mice;
p = 0.03 b 0.05) (Fig. 4C). Thus the expansion in the size of the
neurosphere forming NPC pool is positively correlated with an increase
in the number of proliferating cells within the DG, identical to what is
observed in the SVZ NPC niche.
Since the proliferating cells in the DG are neurogenic, we predicted
that CsA administration in vivowould lead to an increase in the number
of cells expressing doublecortin (DCX), a marker for newborn DG neu-
rons between 1 to 14 days after their generation (Brown et al., 2003). In-
deed, we observed a signiﬁcant 1.8-fold increase in the number of
DCX+ cells after 7 days of CsA infusion (57.5 ± 8.0 vs. 32.0 ± 1.3
cells per section; CsA vs. vehicle treatedmice, p=0.03 b 0.05) (Fig. 4D).
Based on these observations we made the strong prediction that if
CsA is enhancing cell survival then we should observe an increase in
the number of newborn neurons in the DG of CsA-treated mice. Previ-
ous studies have determined that 50% of the newborn neurons die be-
tween 7 and 14 days after birth (McDonald and Wojtowicz, 2005).
Fig. 4. Infusion of cyclosporin A in vivo increases BrdU+, Ki67+, and DCX+ cells. (A) Schematic of experimental paradigm. Adult mice were implanted with subcutaneous pumps con-
taining CsA (15mg/kg/day) or vehicle for 7 days. Mice received 3 injections of BrdU prior to sacriﬁce on day 7. (B) Representative images of BrdU+ cells (red) in the DG from vehicle and
CsA infused mice. Dotted lines border the area of the dentate gyrus. CsA infusion resulted in a 1.7-fold increase in the number of BrdU+ cells per section (9.8 ± 1.1 vs. 5.9 ± 0.9 cells per
section; CsA vs vehicle infused mice, p = 0.02 b 0.05) (N= 8mice per group). (C) Representative images of Ki67+ cells (green) and nuclei (blue). CsA infused mice exhibited a 2.3-fold
increase in the number of Ki67+ cells per section over control animals (9.6 ± 2.9 vs. 5.8 ± 2.5 cells per section; CsA vs. vehicle infused mice; p = 0.03 b 0.05) (N = 6 mice per group).
(D) Representative image of DCX+ cells (red) and nuclei (blue). Animals that received CsA pumps exhibited a 1.8-fold increase in the number of DCX+ cells per section over control an-
imals (57.5 ± 8.0 vs. 32.0 ± 1.3 cells per section; CsA vs. vehicle treated mice, p = 0.03 b 0.05) (N = 3 mice per group). Scale bars represent 100 μm.
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(when half of the newly born neurons die). Accordingly, to determine
whether CsA is improving the survival rates of newly born proliferating
neurons above baseline conditions we prelabeled a cohort of cells by
injectingmice with BrdU once daily for seven days prior to CsA infusion
in vivo for 7 days (Fig. 5A). If CsAwas enhancing the survival of newborn
neurons, an increase in the numbers of cells positive for both BrdU and
DCXwould be observed. As this region has continuous addition of new-
born neurons, we also predict CsAwill increase the number of cells pos-
itive for only DCX with no change in cells positive for only BrdU if thiswas solely a survival effect and not a result of enhanced proliferation.
Indeed, we found that mice that received CsA infusion had a 1.8-fold in-
crease in the numbers of DCX/BrdU double positive cells (13 ± 1.2 vs.
7.3 ± 1.6 double-positive cells per section; CsA vs. vehicle treated
mice respectively, *p=0.02 b 0.05) (Fig. 5B).We also observed a signif-
icant 1.26-fold increase in DCX+ cells following exposure to CsA (39 ±
1.2 vs. 31± 1.6 DCX+ cells per section; CsA vs. vehicle treated mice re-
spectively, **p = 0.006 b 0.05) without a signiﬁcant change in BrdU+
cells (9.6 ± 1.6 vs. 8.2 ± 1.8 BrdU+ cells per section; CsA vs. vehicle
treated mice respectively, p = 0.59) (Fig. 5B). Together, these ﬁndings
Fig. 5. Infusion of cyclosporin A in vivo increases the survival of newborn neurons. (A) Schematic of experimental paradigm. Adult mice received daily injections of BrdU for 7 days and
were subsequently implantedwith subcutaneous CsA or vehicle pumps fromday 7–14. (B)Mice that received CsA pumps exhibited a 1.8-fold increase in the numbers of DCX/BrdUdouble
positive cells (13±1.2 vs. 7.3±1.6 double-positive cells per section; CsA vs. vehicle treatedmice respectively, *p=0.02 b 0.05).We also observeda signiﬁcant 1.26-fold increase inDCX+
cells following exposure to CsA (39 ± 1.2 vs. 31 ± 1.6 DCX+ cells per section; CsA vs. vehicle treated mice respectively, **p = 0.006 b 0.05) with no signiﬁcant increase in BrdU+ cells
(9.6 ± 1.6 vs. 8.2 ± 1.8 BrdU+ cells per section; CsA vs. vehicle treatedmice respectively, p = 0.59). 4 mice per group. (C) Representative images of DG (BrdU, green; DCX, red). Arrows
indicate BrdU + DCX+ cells. Scale bars represent 100 μm.
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neurons in the DG of the adult mouse.4. Discussion
In this study, we examined the behavior of NPCs in response to CsA
using both in vitro and in vivo models. The in vitro and in vivo studies
show that CsA effectively increases the size of the NPC population.
Given that SVZ-derived neurospheres are comprised of approximately
1% stem cells and 99% progenitors (Morshead et al., 2002), the signiﬁ-
cant change in the numbers of neurospheres accompanied by no change
in size of the neurospheres suggest that CsA effects in theDGare speciﬁc
to precursors that have more stem cell-like characteristics rather than
downstream progenitors. This increase in the numbers of NPCs lead to
a concomitant increase in the numbers of proliferating NPCs and pro-
moted NPC survival of newborn neurons that normally undergo cell
death, effectively enhancing neurogenesis.The ﬁndings reported herein are similar towhatwas observed in the
SVZ (Hunt et al., 2010) with CsA having pro-survival effects. However,
CsA does not appear to promote survival of all precursor cells (stem
and progenitors) within the DG as the size of the neurospheres does
not increase as was seen with the SVZ neurospheres. The ability to in-
crease the numbers of neurospheres with continued passage of CsA-
exposed DG neurospheres is consistent with CsA promoting survival
of the stem cell population speciﬁcally. Additionally, CsA did not affect
the differentiation proﬁle of SVZ neurosphere cells however in the DG,
the neurospheres that formed in the continued presence of CsA gave
rise to increased numbers of neurons over time. Notably, we observed
this increase in neurons when DG-derived neurospheres were main-
tained in CsA for 3 passages (approximately 3 weeks) whereas the
SVZ-derived neurosphere differentiation proﬁle was examined after
only 1 week of exposure. It would be interesting to examine the differ-
entiation proﬁle of SVZ-derived neurospheres after 3 weeks of CsA ex-
posure to determine if the effects were consistent between these two
neurogenic precursor pools in the adult brain.
86 A. Chow, C.M. Morshead / Stem Cell Research 16 (2016) 79–87Our in vivo ﬁndings show that CsA increases the NPC pool by
increasing the number of BrdU+, Ki67+, andDCX+ cells in theDG fol-
lowing 7 days of CsA administration. With respect to the mechanism,
our ﬁndings are consistent with a pro-survival effect of CsA rather
than a proliferative effect. In the presence of CsA, we observed a reduc-
tion in cell death in vitro and an increase in BrdU+DCX+ cells without
dilution ofweek-old BrdU labeling,whichwould have been indicative of
increased proliferation, in vivo. Recent work has demonstrated that the
pro-survival effects of CsA are mediated by the inhibition of the mito-
chondrial permeability transition (MPT) pore formation (Sachewsky
et al., 2014). In this study by Sachewsky et al. (2014), enhanced cell sur-
vival was observed using a non-immunosuppressive analog of CsA,
NIM811,whichwas able to completelymimic the in vitro and in vivo ef-
fects of CsA. NIM811 binds to cyclophilin D in the mitochondria. Most
interesting, CsA and NIM811 administrations following strokewere suf-
ﬁcient to promote functional recovery (Erlandsson et al., 2011;
Sachewsky et al., 2014). This enhanced behavioral recovery following
cortical stroke suggests that increasing the size of the NPC pool may
be an important step in promoting tissue repair and functional recovery.
We suggest that similar pro-survival effects of the NPC pool are occur-
ring within the DG NPC population in response to CsA.
Unlike what was observed in Hwang et al. (2010), we did not ob-
serve any differences in the numbers or length of the dendrites in our
CsA treated versus untreated brains. One possible explanation for this
difference is that the administration of CsA differed between the two
studies. Most notable was that Hwang et al. (2010) looked at 2 weeks
post-CsA (administered intraperitoneally with daily injections) where-
as our study looked after 1 week of CsA administration (given systemi-
cally through osmotic mini-pumps). As such, we suggest that Hwang
et al. (2010) were examining a more mature phenotype that resulted
from the increased exposure to CsA. The pro-survival effects of CsA
resulted in more mature phenotypes at longer survival times.
Our in vitro and in vivo studies show an increase in neurogenesis in
the presence of CsA. Ourﬁndings are consistentwith the idea that CsA is
enhancing the survival of DGNPCs and these cells proliferate to give rise
to newly born neurons. We cannot rule out the possibility that the DG
contains a population of latent NPCs which are activated by CsA and
promoting their proliferation. Indeed, recent studies have suggested
that the neurogenic SVZ of the forebrain contains a population of quies-
cent neural stem cells (Codega et al,. 2014). A study by Walker et al.
(2008) observed a 3-fold increase in the number of neurospheres gen-
erated from adult mouse DG following neural excitation using
depolarizing levels of potassium chloride. Interestingly, the neural exci-
tation resulted in the increase in the number of neurospheres that gave
rise to neurons in vitro. We have previously demonstrated that the
mechanism by which CsA promotes the survival of SVZ NPCs is through
binding with cyclophilin D and inhibition of mitochondrial pore forma-
tion, thereby blocking apoptosis (Sachewsky et al., 2014).We propose a
similar mechanism for NPC survival in the DG. However, further inves-
tigation is needed to rule out the activation of a latent population of DG
NPCs.
The observed increase in neurogenesis in vivo has implications for
regenerative repair strategies in regard to brain injuries. Injuries in
the hippocampus can lead to impaired spatial recognition, learning,
and memory. Studies have shown that impairing the process of
neurogenesis also impairs spatial recognition and learning (Zhao et al.,
2003), highlighting the importance of neurogenesis in these tasks. One
study showed that an approximately 3-fold increase in adult mouse
neurogenesis through exercise led to approximately 50% improvement
in performance in the Morris water maze spatial recognition task over
control mice (van Praag et al., 1999). A positive correlation between
promoting neurogenesis in the hippocampus and cognitive function re-
covery has been shown by intraventricular infusion of S100B, a neuro-
trophic protein secreted by astrocytes, and subsequent cognitive tests
using the Morris water maze (Kleindienst et al., 2005). More recently,
metformin, a drug used to treat type II diabetes, has also been shownto promote neurogenesis in the hippocampus and improve behavior
in the Morris water maze (Wang et al., 2012). Another recent study in-
volving a different factor, prolactin, also showed a correlation between
neurogenesis and cognitive function.Mice that were deﬁcient in prolac-
tin exhibited decreased neurosphere formation in vitro and decreased
BrdU+ cells in the DG in vivo (Walker et al., 2012). Prolactin-null
mice also displayed poorer performance in cognitive tasks such as the
Morris water maze and this deﬁciency was rescued by infusion of pro-
lactin into the hippocampus (Walker et al., 2012).
However, it remains unclear as to whether increasing adult hippo-
campal neurogenesis is sufﬁcient on its own to improve cognitive func-
tion as prior studies increased neurogenesis as a consequence of an
intervention such as drugs or exercise. One study by Sahay et al.
(2011) genetically and cell autonomously increased neurogenesis in
the mouse DG and found that while this improved pattern separation
tasks, they saw no improvement in spatial learning or memory tasks.
Also, hippocampal function can be modiﬁed by factors beyond
neurogenesis such as dendritic complexity, synaptogenesis, and angio-
genesis. Given that existing neurons, glial, and vascular cells far out-
number adult-born neurons, it can be difﬁcult to wholly attribute
cognitive functional improvements as a result of an intervention to
neurogenesis alone (Ho et al., 2013). Nonetheless, adult neurogenesis
plays a role in cognitive functional performance and it remains a key
process in age-related cognitive declines, neurodegenerative diseases,
and repair after injury (Yau et al., 2014). Our studies show a signiﬁcant
increase in immature neurons after CsA exposure, suggesting that
future studies to examine whether CsA leads to improvements in the
functional performance of the hippocampus, in normal or diseased con-
ditions, may be warranted.
The in vivo localization of NPCs and their ability to be isolated
in vitro lead to two potential cell-based repair strategies: (1) exogenous
repair where NPCs are isolated and expanded in vitro and transplanted
into the damaged brain and (2) endogenous repair which involves acti-
vation of resident NPCs to promote tissue repair. The ﬁnding that CsA is
able to regulate cell survival, in the absence of mitogenic effects, sug-
gests that CsA may be a good candidate molecule to enhance self-
repair of the injured brain and to treat age-related decline in cognitive
function.
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